Nordion Shares How the Science of Irradiation is Solving Today’s Unique Global Product Challenges

Industry leaders hear about the latest irradiation developments at IMRP 2013

OTTAWA, Ontario–(BUSINESS WIRE)–Nov. 4, 2013Nordion, a leading supplier of Cobalt-60 and a global leader in the design and construction of commercial gamma irradiation systems, today joins the International Irradiation Association (iiA) and other industry leaders at the 2013 International Meeting on Radiation Processing (IMRP) in Shanghai, China…

Collaboration with Adesto Technologies and Nordion Confirms Gamma Irradiation Tolerance of CBRAM® Non-Volatile Memory

Capability Opens New Market Opportunities to Ultra-Low Power Memory Products

OTTAWA, Canada–(BUSINESS WIRE)–Oct. 16, 2013Adesto Technologies, a memory solutions provider delivering innovative products for code and data storage applications, and Nordion, with global expertise in the design and construction of commercial gamma irradiation systems, today announced the successful completion of gamma irradiation testing of Adesto’s CBRAM non-volatile memory products…

Nordion Completes Divestiture of Targeted Therapies Business to BTG plc

OTTAWA, Ontario–(BUSINESS WIRE)–Jul. 15, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today announced that it has completed the divestiture of its Targeted Therapies business to BTG plc (LSE: BTG), an international specialist healthcare company based in London, United Kingdom for a cash purchase price of US$200 million…

Nordion Enters into Agreement to Divest Targeted Therapies Business to BTG plc

OTTAWA, Ontario–(BUSINESS WIRE)–May. 23, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced that it has entered into an agreement to divest its Targeted Therapies business to BTG…

World Congress on Interventional Oncology to Present Live TheraSphere® Administration

Interventional Oncology Team at Northwestern Memorial Hospital to perform hepatocellular carcinoma liver-directed treatment with live narration

OTTAWA, Ontario–(BUSINESS WIRE)–May. 16, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, today announced that for the second consecutive year, organizers of the World Congress on Interventional Oncology (WCIO) 2013 will host a live administration of TheraSphere®, Nordion’s Yttrium-90 (Y-90) glass microspheres for the treatment of hepatocellular carcinoma (HCC)…

Nordion Signs Contract Manufacturing Agreement with Navidea Biopharmaceuticals

OTTAWA, Ontario–(BUSINESS WIRE)–May. 15, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today announced it has signed a contract manufacturing agreement with Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals…

Nordion to Host Interactive TheraSphere(R) Educational Session at the SIR Annual Scientific Meeting 2013

Session to complement Nordion’s educational portfolio for physicians

OTTAWA, Ontario–(BUSINESS WIRE)–Apr. 10, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, will host an educational session called TheraSphere® Test Flight Interactive: How to Treat or Should I Treat?at the Society for Interventional Radiologists (SIR) Annual Scientific Meeting, taking place April 13-18 in New Orleans, Louisiana…

Nordion to Host European-Based Educational and Scientific Meetings for Liver Cancer Specialists

Meetings designed to support TheraSphere® treatment growth and expansion in Europe

OTTAWA, Ontario–(BUSINESS WIRE)–Apr. 9, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, will host two upcoming educational and scientific meetings to support the growth and expansion of TheraSphere® treatment in Europe…

Nordion Launches a New and Improved TheraSphere(R) Website to Meet the Needs of Liver Cancer Physicians, Patients and Caregivers Worldwide

TheraSphere.com provides unique resources and targeted information about this innovative radioembolization therapy

OTTAWA, Ontario–(BUSINESS WIRE)–Mar. 5, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced today that it has launched a new and improved, intuitive, feature-rich TheraSphere® website, providing liver cancer patients and physicians with customized TheraSphere® resources that include medical and clinical information, convenient online ordering, and innovative digital resources…

Nordion Appoints Mr. Grant Gardiner as SVP and General Counsel

OTTAWA, Ontario–(BUSINESS WIRE)–Jan. 28, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today announced it is appointing Grant Gardiner as Senior Vice President, General Counsel & Corporate Secretary. Mr. Gardiner will serve as the Corporation’s legal officer responsible for all global legal matters, effective March 18, 2013…